Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
NCT07077902Phase 2Completed
- Sponsor
- Tulane University
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast vehicle cream in hidradenitis suppurativa (HS), sponsored by Tulane University. Started Sep 2025; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT07077902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07077902.